Pyrimidyl derivatives as protein kinase inhibitors

Details for Australian Patent Application No. 2007338404 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Reiff, Ulrike; Schaefer, Wolfgang; Koerner, Matthias; Voss, Edgar; Weigand, Stefan; Georges, Guy; Kolm, Irene

Agent Davies Collison Cave

Pub. Number AU-A-2007338404

PCT Pub. Number WO2008/077548

Priority 06026650.9 22.12.06 EP

Filing date 19 December 2007

Wipo publication date 3 July 2008

International Classifications

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07F 7/08 (2006.01) Compounds containing elements of the 4th Group of the Periodic System

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/077548 Priority application(s): WO2008/077548

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338406-Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase

2007338403-shRNA-mediated inhibition of expression of alpha-1. 6-fucosyltransferase